Latest Insider Trading
Filed: 2026-01-29
Key Insights
- Insider Arnold M. Baskies, a director at Anixa Biosciences, acquired 10,000 shares of the company's common stock on January 28, 2026 at $3.04 per share, increasing his direct beneficial ownership to 135,000 shares.
- This insider purchase suggests Baskies has a positive outlook on the company's future prospects and is willing to invest his own capital, which could be a bullish signal for investors.
- The size of the purchase, representing a substantial increase in Baskies' personal stake, indicates he believes the stock is undervalued and has significant upside potential.